血清胃蛋白酶原Ⅰ、Ⅱ及胃泌素17检测对慢性萎缩性胃炎的诊断价值
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

眉山市科技计划(指导性)项目(2019KJZD36)


Early diagnosis of serum pepsinogen Ⅰ, Ⅱ and gastrin 17 in patients with chronic atrophic gastritis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨血清胃蛋白酶原Ⅰ(PG-Ⅰ)、Ⅱ(PG-Ⅱ)和胃泌素17(G-17)检测对慢性萎缩性胃炎(CAG)的诊断价值。方法 选取2019年7月~2020年7月我院检查确诊的慢性萎缩性胃炎患者112例作为观察组,同时选取我院同期检查的慢性非萎缩性胃炎患者112例作为对照组。对两组患者血清中PG-Ⅰ、PG-Ⅱ、PG-Ⅰ/PG-Ⅱ(PGR)及G-17水平进行荧光免疫法检测,上述指标单用与联合应用对CAG的诊断效能及诊断CAG的特异性和灵敏性ROC曲线进行分析。同时对两组幽门螺杆菌(Hp)检测,比较观察组Hp阴性与阳性患者血清PG-Ⅰ、PG-Ⅱ及G-17水平。结果 与对照组比较,观察组患者血清PG-Ⅰ、PGR及G-17水平均显著降低(均P<0.05);在PG-Ⅱ水平方面,两组间比较差异无统计学意义(P>0.05);观察组中胃体萎缩与全胃多灶萎缩、胃窦萎缩相比,PG-Ⅰ、PG-Ⅱ及PGR水平均显著降低,G-17水平显著提高(均P<0.05);采用ROC曲线对PG-Ⅰ、PG-Ⅱ、G-17及联合指标绘制CAG曲线下面积,依次分别为0.895、0.873、0.881、0.903。与对照组比较,观察组患者Hp阳性率显著提高(P<0.05);经对观察组患者分析,其Hp阳性患者与Hp阴性患者PG-Ⅰ、PG-Ⅱ、PGR、G-17水平比较差异均无统计学意义(P>0.05)。结论 血清PG-Ⅰ、PGR及G-17水平与CAG的发生、发展具有一定的关系,临床对血清、PGR及G-17水平进行联合检测对该疾病的早期诊断具有较高价值,有助于疾病早期治疗。

    Abstract:

    Objective To explore the diagnostic value of serum pepsinogen Ⅰ(PG-Ⅰ), Ⅱ(PG-Ⅱ) and gastrin 17(G-17) in the diagnosis of chronic atrophic gastritis(CAG). Methods We selected 112 patients with chronic atrophic gastritis diagnosed in our hospital from July 2019 to July 2020 as the observation group, and selected 112 patients with chronic non-atrophic gastritis who were examined in our hospital during the same period as the control group. The levels of PG-Ⅰ, PG-Ⅱ, PG-Ⅰ/PG-Ⅱ(PGR) and G-17 in the serum of the two groups of patients were detected by fluorescence immunoassay. The diagnostic efficiency and the specificity and sensitivity of the diagnosis of CAG were analyzed by ROC curve. The three indicators and indicators combined to diagnose the specificity and sensitivity of the above diseases are analyzed by ROC curve. Results Compared with the control group, the observation group patients' serum PG-Ⅰ, PGR and G-17 levels were significantly reduced, and the difference was significant(P<0.05). In terms of PG-Ⅱ levels, there was no significant difference between the two groups(P>0.05). In the observation group, gastric body atrophy was compared with multifocal atrophy of whole stomach and antral atrophy, the gastric atrophy group PG-Ⅰ, PG-Ⅱ and PGR levels were significantly reduced, and the G-17 level was significantly increased(P<0.05); The ROC curve was used to draw the area under the CAG curve for PG-Ⅰ, PG-Ⅱ, G-17 and the combined index, which were 0.895, 0.873, 0.881, and 0.903 respectively. Compared with the control group, the positive rate of Hp in the observation group increased significantly, the difference has significant(P<0.05). The analysis of the observation group showed that the Hp-positive patients and the Hp-negative patients PG-Ⅰ, PG-Ⅱ, G-17 There was no significant difference in level comparison(P>0.05). Conclusion Serum PG-Ⅰ, PGR and G-17 levels have a certain relationship with the occurrence and development of CAG. The clinical combined detection of serum PG-Ⅰ, PGR and G-17 levels is of high value for the early diagnosis of the disease, Which is helpful for early treatment of disease.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-07-20
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司